[Form 4] Crescent Capital BDC, Inc. Common stock Insider Trading Activity
Raymond Barrios, a Managing Director and officer of Crescent Capital BDC, Inc. (CCAP), reported insider purchases on 08/25/2025. The filing shows two separate non-derivative acquisitions of common stock: 2,230 shares at $15.6316 and 1,015 shares at $15.62, both marked with transaction code P (pursuant to a written plan). After these transactions Barrios beneficially owned 19,177 shares directly. The report also notes 1,181 shares acquired through dividend reinvestment in 2025 that were not previously reported under Rule 16a-11. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
Raymond Barrios, Managing Director e dirigente di Crescent Capital BDC, Inc. (CCAP), ha segnalato acquisti da insider in data 25/08/2025. Il documento indica due distinti acquisti non derivativi di azioni ordinarie: 2.230 azioni a $15,6316 e 1.015 azioni a $15,62, entrambi riportati con il codice di transazione P (ai sensi di un piano scritto). Dopo queste operazioni Barrios deteneva beneficiariamente 19.177 azioni direttamente. La relazione segnala inoltre 1.181 azioni acquisite mediante reinvestimento dei dividendi nel 2025 che non erano state precedentemente comunicate ai sensi della Rule 16a-11. Il Modulo 4 è stato firmato da un procuratore il 26/08/2025.
Raymond Barrios, Managing Director y directivo de Crescent Capital BDC, Inc. (CCAP), informó compras de insider el 25/08/2025. La presentación muestra dos adquisiciones no derivadas de acciones comunes: 2.230 acciones a $15,6316 y 1.015 acciones a $15,62, ambas indicadas con el código de transacción P (conforme a un plan por escrito). Tras estas operaciones, Barrios poseía beneficiariamente 19.177 acciones de forma directa. El informe también señala 1.181 acciones adquiridas mediante reinversión de dividendos en 2025 que no se habían notificado anteriormente según la Rule 16a-11. El Formulario 4 fue firmado por un apoderado el 26/08/2025.
레이먼드 바리오스(Raymond Barrios)씨는 Crescent Capital BDC, Inc. (CCAP)의 전무이사 겸 임원으로서 2025-08-25에 내부자 매입을 신고했습니다. 제출 서류에는 보통주에 대한 두 건의 비파생 취득이 기재되어 있으며, 2,230주를 주당 $15.6316에, 1,015주를 주당 $15.62에 취득한 것으로 되어 있고 두 거래 모두 서면 계획에 따른 거래 코드 P로 표시되어 있습니다. 이 거래들 이후 바리오스는 직접적으로 19,177주를 실질적으로 보유하게 되었습니다. 보고서에는 또한 2025년에 배당 재투자를 통해 취득한 1,181주가 Rule 16a-11에 따라 이전에 보고되지 않았던 것으로 기재되어 있습니다. Form 4는 2025-08-26에 대리인(Attorney-in-fact)이 서명했습니다.
Raymond Barrios, Managing Director et dirigeant de Crescent Capital BDC, Inc. (CCAP), a déclaré des achats d'initiés le 25/08/2025. Le dépôt indique deux acquisitions non dérivées d'actions ordinaires : 2 230 actions à $15,6316 et 1 015 actions à $15,62, toutes deux libellées avec le code de transaction P (conformément à un plan écrit). Après ces opérations, Barrios détenait à titre bénéficiaire 19 177 actions en direct. Le rapport signale également 1 181 actions acquises par réinvestissement des dividendes en 2025 qui n'avaient pas été précédemment rapportées en vertu de la Rule 16a-11. Le Formulaire 4 a été signé par un mandataire le 26/08/2025.
Raymond Barrios, Managing Director und leitender Angestellter von Crescent Capital BDC, Inc. (CCAP), meldete Insiderkäufe am 25.08.2025. Die Einreichung weist zwei getrennte nicht-derivative Erwerbe von Stammaktien aus: 2.230 Aktien zu $15,6316 und 1.015 Aktien zu $15,62, beide mit Transaktionscode P (gemäß einem schriftlichen Plan) gekennzeichnet. Nach diesen Transaktionen hielt Barrios unmittelbar wirtschaftlich 19.177 Aktien. Der Bericht vermerkt außerdem 1.181 Aktien, die 2025 durch Dividendenreinvestition erworben wurden und zuvor nicht nach Rule 16a-11 gemeldet worden waren. Das Formblatt 4 wurde am 26.08.2025 von einem Bevollmächtigten unterzeichnet.
- Insider purchases of 3,245 shares on 08/25/2025 indicating continued insider accumulation
- Disclosure of 1,181 dividend-reinvested shares in 2025 corrects prior non-reporting under Rule 16a-11
- None.
Insights
TL;DR: Officer purchased additional shares via a Rule 10b5-1 plan and dividend reinvestment, modestly increasing direct holdings.
The reported purchases on 08/25/2025 total 3,245 common shares at prices around $15.62, consistent with routine accumulation by an insider. Transaction code P indicates the trades were made pursuant to a written plan, which reduces timing risk concerns but limits informational content about intent. The inclusion of 1,181 dividend-reinvested shares clarifies prior under-reporting under Rule 16a-11. For investors, these trades are modest in size relative to typical institutional stakes and do not by themselves signal a material change in ownership or control.
TL;DR: Form 4 shows compliant disclosures of purchases and dividend reinvestment; filings appear routine and properly executed by attorney-in-fact.
The filing identifies Raymond Barrios as a reporting officer and uses correct Section 16 reporting format. Purchases coded P suggest pre-established trading plan usage, which aligns with best practices for insiders to avoid allegations of opportunistic timing. The late reporting of dividend-reinvested shares is disclosed within the filing, addressing a prior omission. No transfers, dispositions, option exercises, or other governance concerns are disclosed here.
Raymond Barrios, Managing Director e dirigente di Crescent Capital BDC, Inc. (CCAP), ha segnalato acquisti da insider in data 25/08/2025. Il documento indica due distinti acquisti non derivativi di azioni ordinarie: 2.230 azioni a $15,6316 e 1.015 azioni a $15,62, entrambi riportati con il codice di transazione P (ai sensi di un piano scritto). Dopo queste operazioni Barrios deteneva beneficiariamente 19.177 azioni direttamente. La relazione segnala inoltre 1.181 azioni acquisite mediante reinvestimento dei dividendi nel 2025 che non erano state precedentemente comunicate ai sensi della Rule 16a-11. Il Modulo 4 è stato firmato da un procuratore il 26/08/2025.
Raymond Barrios, Managing Director y directivo de Crescent Capital BDC, Inc. (CCAP), informó compras de insider el 25/08/2025. La presentación muestra dos adquisiciones no derivadas de acciones comunes: 2.230 acciones a $15,6316 y 1.015 acciones a $15,62, ambas indicadas con el código de transacción P (conforme a un plan por escrito). Tras estas operaciones, Barrios poseía beneficiariamente 19.177 acciones de forma directa. El informe también señala 1.181 acciones adquiridas mediante reinversión de dividendos en 2025 que no se habían notificado anteriormente según la Rule 16a-11. El Formulario 4 fue firmado por un apoderado el 26/08/2025.
레이먼드 바리오스(Raymond Barrios)씨는 Crescent Capital BDC, Inc. (CCAP)의 전무이사 겸 임원으로서 2025-08-25에 내부자 매입을 신고했습니다. 제출 서류에는 보통주에 대한 두 건의 비파생 취득이 기재되어 있으며, 2,230주를 주당 $15.6316에, 1,015주를 주당 $15.62에 취득한 것으로 되어 있고 두 거래 모두 서면 계획에 따른 거래 코드 P로 표시되어 있습니다. 이 거래들 이후 바리오스는 직접적으로 19,177주를 실질적으로 보유하게 되었습니다. 보고서에는 또한 2025년에 배당 재투자를 통해 취득한 1,181주가 Rule 16a-11에 따라 이전에 보고되지 않았던 것으로 기재되어 있습니다. Form 4는 2025-08-26에 대리인(Attorney-in-fact)이 서명했습니다.
Raymond Barrios, Managing Director et dirigeant de Crescent Capital BDC, Inc. (CCAP), a déclaré des achats d'initiés le 25/08/2025. Le dépôt indique deux acquisitions non dérivées d'actions ordinaires : 2 230 actions à $15,6316 et 1 015 actions à $15,62, toutes deux libellées avec le code de transaction P (conformément à un plan écrit). Après ces opérations, Barrios détenait à titre bénéficiaire 19 177 actions en direct. Le rapport signale également 1 181 actions acquises par réinvestissement des dividendes en 2025 qui n'avaient pas été précédemment rapportées en vertu de la Rule 16a-11. Le Formulaire 4 a été signé par un mandataire le 26/08/2025.
Raymond Barrios, Managing Director und leitender Angestellter von Crescent Capital BDC, Inc. (CCAP), meldete Insiderkäufe am 25.08.2025. Die Einreichung weist zwei getrennte nicht-derivative Erwerbe von Stammaktien aus: 2.230 Aktien zu $15,6316 und 1.015 Aktien zu $15,62, beide mit Transaktionscode P (gemäß einem schriftlichen Plan) gekennzeichnet. Nach diesen Transaktionen hielt Barrios unmittelbar wirtschaftlich 19.177 Aktien. Der Bericht vermerkt außerdem 1.181 Aktien, die 2025 durch Dividendenreinvestition erworben wurden und zuvor nicht nach Rule 16a-11 gemeldet worden waren. Das Formblatt 4 wurde am 26.08.2025 von einem Bevollmächtigten unterzeichnet.